These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33824279)

  • 1. Transcriptomic signaling pathways involved in a naturalistic model of inflammation-related depression and its remission.
    Moisan MP; Foury A; Dexpert S; Cole SW; Beau C; Forestier D; Ledaguenel P; Magne E; Capuron L
    Transl Psychiatry; 2021 Apr; 11(1):203. PubMed ID: 33824279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.
    Sheehan DV; Harnett-Sheehan K; Spann ME; Thompson HF; Prakash A
    Int Clin Psychopharmacol; 2011 Mar; 26(2):75-83. PubMed ID: 21102344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbid anxiety in late-life depression: Relationship with remission and suicidal ideation on venlafaxine treatment.
    Saade YM; Nicol G; Lenze EJ; Miller JP; Yingling M; Wetherell JL; Reynolds CF; Mulsant BH
    Depress Anxiety; 2019 Dec; 36(12):1125-1134. PubMed ID: 31682328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomic predictors of inflammation-induced depressed mood.
    Cho JH; Irwin MR; Eisenberger NI; Lamkin DM; Cole SW
    Neuropsychopharmacology; 2019 Apr; 44(5):923-929. PubMed ID: 30643228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant Effect of Ketamine on Inflammation-Mediated Cytokine Dysregulation in Adults with Treatment-Resistant Depression: Rapid Systematic Review.
    Sukhram SD; Yilmaz G; Gu J
    Oxid Med Cell Longev; 2022; 2022():1061274. PubMed ID: 36160713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNFAIP3, a negative regulator of the TLR signaling pathway, is a potential predictive biomarker of response to antidepressant treatment in major depressive disorder.
    Hung YY; Lin CC; Kang HY; Huang TL
    Brain Behav Immun; 2017 Jan; 59():265-272. PubMed ID: 27640899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
    Olié JP; Gourion D; Montagne A; Rostin M; Poirier MF
    Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial.
    Baune BT; Sampson E; Louise J; Hori H; Schubert KO; Clark SR; Mills NT; Fourrier C
    Eur Neuropsychopharmacol; 2021 Dec; 53():34-46. PubMed ID: 34375789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatment.
    Mellon SH; Wolkowitz OM; Schonemann MD; Epel ES; Rosser R; Burke HB; Mahan L; Reus VI; Stamatiou D; Liew CC; Cole SW
    Transl Psychiatry; 2016 May; 6(5):e821. PubMed ID: 27219347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal C-reactive protein blood levels as a specific biomarker of major depression and non-remission under antidepressants in schizophrenia.
    Fond G; Micoulaud-Franchi JA; Faugere M; Boyer L; Faget-Agius C; Lançon C; Richieri R; Cermolacce M
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109800. PubMed ID: 31676465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder.
    Lewis-Fernández R; Lam P; Lucak S; Galfalvy H; Jackson E; Fried J; Rosario M; de la Cruz AA; Sánchez-Lacay A; Díaz S; Schneier F
    J Clin Psychopharmacol; 2016 Dec; 36(6):710-715. PubMed ID: 27755218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy outcomes in the MDD-1 India study: First episode major depressive disorder outcomes in antidepressant-treated real-world patients in India.
    Andrade C; De Sousa A; Shah N
    J Psychopharmacol; 2020 Oct; 34(10):1098-1104. PubMed ID: 32684093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using prefrontal and midline right frontal EEG-derived theta cordance and depressive symptoms to predict the differential response or remission to antidepressant treatment in major depressive disorder.
    de la Salle S; Jaworska N; Blier P; Smith D; Knott V
    Psychiatry Res Neuroimaging; 2020 Aug; 302():111109. PubMed ID: 32480044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3 fatty acids for depression in adults.
    Appleton KM; Sallis HM; Perry R; Ness AR; Churchill R
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004692. PubMed ID: 26537796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant Expression of Intracellular let-7e, miR-146a, and miR-155 Correlates with Severity of Depression in Patients with Major Depressive Disorder and Is Ameliorated after Antidepressant Treatment.
    Hung YY; Wu MK; Tsai MC; Huang YL; Kang HY
    Cells; 2019 Jun; 8(7):. PubMed ID: 31252530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. History of major depression is associated with neuropsychiatric symptoms but not systemic inflammation in a cross-sectional study in obese patients.
    Oriolo G; Huet L; Dexpert S; Beau C; Forestier D; Ledaguenel P; Magne E; Martin-Santos R; Capuron L
    Brain Behav Immun; 2019 Feb; 76():215-222. PubMed ID: 30476563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of residual cognitive disturbances by early response of depressive symptoms to antidepressant treatments in patients with major depressive disorder.
    Sumiyoshi T; Hoshino T; Mishiro I; Hammer-Helmich L; Ge H; Moriguchi Y; Fujikawa K; Fernandez JL
    J Affect Disord; 2022 Jan; 296():95-102. PubMed ID: 34597893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.